medigraphic.com
ISSN 2007-3194 (Impreso)
Órgano de difusión oficial del Instituto Materno Infantil del Estado de México

2016, Número 3

<< Anterior Siguiente >>

Arch Inv Mat Inf 2016; 8 (3)


Eficacia del tratamiento tópico con interferón 85 alfa-2b en el carcinoma escamoso de la superficie ocular. Reporte de caso

De la Campa JJA, O’Shea CGJ

Idioma: Español
Referencias bibliográficas: 23
Paginas: 85-88
Archivo PDF: 559.90 Kb.


RESUMEN

Presentamos un caso de un paciente con neoplasia intraepitelial conjuntivo-corneal manejado con interferón alfa-2b (IFN α-2b) tópico. La neoplasia intraepitelial conjuntivo-corneal (CIN) es la tumoración más frecuente de la superficie ocular. Existen diversos factores de riesgo asociados con la aparición de esta lesión. Otras opciones terapéuticas son tratamiento quirúrgico clásico y terapias coadyuvantes con mitomicina C y 5 fluoracilo (5-FU).


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Gómez-Cabrera CG, Cabrera-Arias JG, Sosa-Palacios O, Ramírez-García LK, Vigoa-Aranguren L. Caracterización epidemiológica de la neoplasia intraepitelial de la conjuntiva en el Instituto Cubano de Oftalmología “Ramón Pando Ferrer”, Rev Cubana Oftalmol, 2014; 27 (1): 100-108.

  2. Mittal R, Rath S, Vemuganti GK. Ocular surface squamous neoplasia - Review of etio-pathogenesis and an update on clinico-pathological diagnosis, Saudi J Ophthalmol, 2013; 27 (3): 177-186.

  3. Hanson RJ, Rubinstein A, Sarangapani S, Benjamin L, Patel CK. Effect of lens epithelial cell aspiration on postoperative capsulorhexis contraction with the use of the AcrySof intraocular lens: randomized clinical trial, J Cataract Refract Surg, 2006; 32 (10): 1621-1626.

  4. McDonnell PJ, Zarbin MA, Green WR. Posterior capsule opacification in pseudophakic eyes, Ophthalmology, 1983; 90 (12): 1548-1553.

  5. Tadros A, Bhatt UK, Abdul-Karim MN, Zaheer A, Thomas PW. Removal of lens epithelial cells and the effect on capsulorhexis size, J Cataract Refract Surg, 2005; 31 (8): 1569-1574.

  6. Davison JA. Capsule contraction syndrome, J Cataract Refract Surg, 1993; 19 (5): 582-589.

  7. Davison JA. Capsular bag distension after endophacoemulsification and posterior chamber intraocular lens implantation, J Cataract Refract Surg, 1990; 16 (1): 99-108.

  8. Hansen SO, Crandall AS, Olson RJ. Progressive constriction of the anterior capsular opening following intact capsulorhexis, J Cataract Refract Surg, 1993; 19 (1): 77-82.

  9. Nishi O, Nishi K. Intraocular lens encapsulation by shrinkage of the capsulorhexis opening, J Cataract Refract Surg, 1993; 19 (4): 544-545.

  10. Sacu S, Menapace R, Buehl W, Rainer G, Findl O. Effect of intraocular lens optic edge design and material on fibrotic capsule opacification and capsulorhexis contraction, J Cataract Refract Surg, 2004; 30 (9): 1875-1882.

  11. Moreno-Montañés J, Sánchez-Tocino H, Rodriguez-Conde R. Complete anterior capsule contraction after phacoemulsification with acrylic intraocular lens and endocapsular ring implantation, J Cataract Refract Surg, 2002; 28 (4): 717-719.

  12. Prinz A, Neumayer T, Buehl W, Vock L, Menapace R, Findl O et al. Rotational stability and posterior capsule opacification of a plate-haptic and an open-loop-haptic intraocular lens, J Cataract Refract Surg, 2011; 37 (2): 251-257.

  13. Saldanha MJ, Benjamin L, Patel CK. Postoperative rotation of a 3-piece loop-haptic acrylic intraocular lens, J Cataract Refract Surg, 2009; 35 (10): 1751-1755.

  14. Ohmi S. Decentration associated with asymmetric capsular shrinkage and intraocular lens size, J Cataract Refract Surg, 1993; 19 (5): 640-643.

  15. Strenn K, Menapace R, Vass C. Capsular bag shrinkage after implantation of an open-loop silicone lens and a poly(methyl methacrylate) capsule tension ring, J Cataract Refract Surg, 1997; 23 (10): 1543-1547.

  16. Chang DF. Comparative rotational stability of single-piece open-loop acrylic and plate-haptic silicone toric intraocular lenses, J Cataract Refract Surg, 2008; 34 (11): 1842-1847.

  17. Pérez de Arcelus M, Aranguren M, Andonegui J. Interferón alfa-2b tópico como primera opción en las neoplasias intraepiteliales corneoconjuntivales, Anales Sis San Navarra, 2012; 35 (1): 137-141.

  18. Toledano-Fernández N, García-Sáenz S, Díaz-Valle D, Arteaga-Sánchez A, Segura-Bedmar M, Lorenzo-Giménez S et al. Interferon alfa-2b treatment in selected cases of recurrent conjunctival intraepithelial neoplasia, Arch Soc Esp Oftalmol, 2003; 78 (5): 265-271.

  19. Mata E, Conesa E, Castro M, Martínez L, de Pablo C, González ML. Conjunctival squamous cell carcinoma: paradoxical response to interferon eyedrops, Arch Soc Esp Oftalmol, 2014; 89 (7): 293-296.

  20. Kusumesh R, Ambastha A, Sinha B, Kumar R. Topical interferon α-2b as a single therapy for primary ocular surface squamous neoplasia, Asia Pac J Ophthalmol (Phila), 2015; 4 (5): 279-282.

  21. Lezcano-Carduz VP, Mingo-Botín D, Durán-Poveda SP. Squamous cell neoplasm of the ocular surface in a patient with psoriasis treated with tumor necrosis factor-alpha inhibitors, Cornea, 2015; 34 (7): 833-834.

  22. Muñoz de Escalona Rojas JE, García-Serrano JL, Cantero-Hinojosa J, Padilla-Torres JF, Bellido-Muñoz RM. Application of interferon alpha 2b in conjunctival intraepithelial neoplasia: predictors and prognostic factors, J Ocul Pharmacol Ther, 2014; 30 (6): 489-494.

  23. Nanji AA, Moon CS, Galor A, Sein J, Oellers P, Karp CL. Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications, Ophthalmology, 2014; 121 (5): 994-1000.




2020     |     www.medigraphic.com